Posted by Michael Walen on Oct 27th, 2026 Elevance Health (NYSE:ELV – Get Free Report) had its price objective lifted by equities researchers at Wells Fargo & Company from $473.00 to $492.00 in a research report issued on Tuesday, Benzinga reports. The brokerage currently has…
Check Out Our Latest Stock Report on Elevance Health The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 18th. Investors of record on Friday, December 4th will be given a dividend of $1.72 per share. The ex-dividend…
Posted by Kim Johansen on Oct 26th, 2026 Elevance Health (NYSE:ELV – Free Report) had its price objective lifted by TD Cowen from $465.00 to $495.00 in a report published on Friday, MarketBeat Ratings reports. TD Cowen currently has a buy rating on the…
Posted by Defense World Staff on Oct 25th, 2026 Here are the key news stories impacting Elevance Health this week: View Our Latest Stock Analysis on Elevance Health Elevance Health operates its health benefits businesses through a portfolio that includes Blue Cross…
Elevance Health, the parent of Anthem and Wellpoint plans, reported a $1.4 billion third-quarter profit on October 21 while covering 487,000 fewer people than a year earlier. Executives told investors that 2026 marks the low point for the company's Medicaid profit margins and that…
Healthcare Services Group, Inc. raised earnings guidance for the full year 2027. For the year, the company raised revenue growth outlook from the mid-single digits to low double digits.... Healthcare Services Group, Inc. Healthcare Services Group, Inc. Raises Earnings Guidance for…
Posted by Kim Johansen on Oct 23rd, 2026 Jefferies Financial Group lowered shares of Elanco Animal Health (NYSE:ELAN – Free Report) from a buy rating to a hold rating in a research note issued to investors on Tuesday, MarketBeat Ratings reports. They…
On October 3, 2023, Morgan Stanley has maintained its rating for Elevance Health (ELV) at Equal-Weight. The firm has raised its price target for the stock from $404.00 to $449.00, marking an increase of 11.14%. The GF Score™ is a comprehensive measure that evaluates a…
Insurance Business Evry Health losses force Globe Life to cut full-year guidance Globe Life Inc. has cut its full-year 2026 earnings guidance. The drag is not its core life insurance business but a group health unit that sells through brokers and…
A stronger-than-forecast third quarter prompted Elevance to raise its full-year profit forecast and increase its 2026 outlook by $2 per share. Management also set a fresh adjusted earnings baseline of $26.75 a share for this year, excluding certain items, and said next year's…
Anthem, Elevance and Salesforce: hiring, expansion, leadership and results.
An article joins this feed when it matches these terms. Each one is also a search of its own.